Evaluation of polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral cells by an immunohistochemical assay

Cancer Epidemiology Biomarkers and Prevention

Volumn 8, Issue 1, 1999, Pages 91-96

  Romano, Gianpiero ^a,d   Sgambato, Alessandro ^a   Boninsegna, Alma ^a   Flamini, Giovanna ^a   Curigliano, Giuseppe ^a   Yang, Qing ^a,e   La Gioia, Vincenzo ^b   Signorelli, Carlo ^a   Ferro, Antonella ^a   Capelli, Giovanni ^a   Santella, Regina M ^c   Cittadini, Achille ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Uff Capo Corpo Sanitario A   (Italy)

^c Columbia School of Public Health ^*  (United States)

^d CATHOLIC UNIVERSITY   (Italy)

^e GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCYCLIC AROMATIC HYDROCARBON;

ARTICLE; CIGARETTE SMOKING; DNA ADDUCT; DNA DETERMINATION; EATING HABIT; FOOD PREFERENCE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUTH CANCER; MOUTH MUCOSA; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; AIR POLLUTANTS, OCCUPATIONAL; ALCOHOL DRINKING; BENZO(A)PYRENE; CARCINOGENS; COLORING AGENTS; COOKERY; DNA ADDUCTS; EMPLOYMENT; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH DISEASES; MOUTH MUCOSA; POLYCYCLIC HYDROCARBONS, AROMATIC; RESIDENCE CHARACTERISTICS; SMOKING; VITAMINS;

EID: 0032999781     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Perera, F. P. Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. J. Natl. Cancer Inst., 88: 496-509, 1996.
2. Doll, S. R. Nature and nurture: possibilities for cancer control. Carcinogenesis (Lond.), 17: 177-184, 1996.
3. IARC. Cancer Incidence in Five Continents. Monographs on the evaluation of carcinogenic risk of chemical to humans. Vol. 8. Lyon. France: IARC, 1987.
4. Doll, R., and Peto, R. The causes of cancer: quantitative estimates of avoidable risk of cancer in the United States today. New York: Oxford University Press, 1981.
5. IARC. Polynuclear aromatic compounds. Monographs on the evaluation of carcinogenic risk of chemical to humans. Vol. 32, Part 1. Lyon. France: IARC, 1983.
6. Brookes, P., and Lawley, P. D. Evidence for the binding of polynuclear aromatic hydrocarbon to the nucleic acids of mouse skin: relation between carcinogenic power of hydrocarbons and their binding to DNA. Nature (Lond.), 202: 781-784, 1964.
7. Pelkonen, O., Vahakangas, K., and Nebert, D. W. Comparison with mutagenesis and tumorigenesis. J. Toxicol. Environ. Health. 6: 1009-1020, 1980.
8. Miller, E. C. Some current perspectives on chemical carcinogenesis in humans and experimental animals. Cancer Res., 38: 1479-1496, 1978.
9. Perera, F. P., Santella R. M., Brenner, D., Poirier, M. C., Munshi, A. A., Fischman, H. K., and Van Ryzin, J. DNA adducts, protein adducts, and sister chromatid exchange in cigarette smokers and nonsmokers. J. Natl. Cancer Inst., 79: 449-455, 1987.
10. Santella, R. M. Application of new techniques for detection of carcinogen adducts to human population monitoring. Mutat. Res., 205: 271-282, 1988.
11. Mumford, J. L., Williams, K., Wilcosky, T. C., Everson, R. B., Young, T. L., and Santella, R. M. A sensitive color ELISA for detecting polcyclic aromatic hydrocarbon-DNA adducts in human tissues. Mutat. Res., 359: 171-177, 1996.
12. 32P postlabeling Skin Pharmacol., 3: 171-179, 1990.
13. Perera, F. P., Hemminki, K., Young, T. L., Brenner, D., Kelly, G., and Santella, R. M. Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells of foundry workers. Cancer Res., 48: 2288-2291, 1988.
14. Al-Atrash, J., Zhang, Y. J., Lin, D., Kadlubar, F., and Santella, R. M. Quantitative immunohistochemical analysis of 4-ABP-DNA adducts in cultured cells and mice: comparison to gas chromatography/mass spectroscopy analysis. Chem. Res. Toxicol., 87: 747-752, 1995.
15. Santella, R. M., Dharmaraja, N., Gasparro, F. P., and Edelson, R. L. Monoclonal antibodies to DNA modified by 8-methoxypsoralen and ultraviolet A light. Nucleic Acids Res., 13: 2533-2544, 1985.
16. Altman, D. G. Practical Statistics for Medical Research London: Chapman and Hall, 1991.
17. Cuzic, J. A. Wilcoxon-type test for trend Stat. Med., 4: 87-90, 1985.
18. Perera, P. F. Environment and cancer: who are susceptible? Science (Washington DC), 278: 1068-1073, 1997.
19. Denissenko, M. F., Pao, A., Tang, M., and Pfeifer, G. P. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science (Washington DC), 274: 133-138, 1996.
20. Zhang, Y. J., Hsu, T. M., and Santella, R. M. Immunoperoxidase detection of polycyclic aromatic hydrocarbon-DNA adducts in oral mucosa cells of smokers and nonsmokers. Cancer Epidemiol. Biomark., 4: 133-138, 1995.
21. Phillips, D. H., Hewer, A., Martin, C. N., Colin Garner, R., and King, M. M. Correlation of DNA adduct levels in human lung with cigarette smoking. Nature (Lond.), 336: 22-29, 1988.
22. 32P postlabeling analysis. Carcinogenesis (Lond.), 18: 339-344, 1997.
23. Curigliano, G., Zhang, Y. J., Wang, L. Y., Flamini, G., Alcini, A., Ratto, C., Giustacchini, M., Alcini, E., Cittadini, A., and Santella, R. M. Immunohistochemical quantitalion of 4-aminobiphenyl-DNA adducts and p53 nuclear over expression in T1 bladder cancer of smokers and nonsmokers. Carcinogenesis (Lond.), 17: 911-916, 1996.
24. Yoneda, G. I., and Kawajiri, K. Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer. Cancer Res., 56: 3725-3730, 1996.
25. Xu, X., Kelsey, K. T., Wiencke, J. K., Wain, J. C., and Christiani, D. C. Cytochrome P450 CYP1A1 Mspl polymorphism and lung cancer susceptibility. Cancer Epidemiol. Biomark. Prev., 5: 687-692, 1996.
26. Bartsh, H., and Hietanen, E. The role of individual susceptibility in cancer burden related to environmental exposure. Environ. Health Perspect., 3: 569-577, 1996.
27. Kato, S., Bowman, E. D., Harrington, A. M., Blomeke, B., and Shields, P. G. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphism in vivo. J. Natl. Cancer Inst., 87: 902-907, 1995.
28. Wei, Q., Cheng, L., Hong, W. K., and Spitz, M. R. Reduced DNA repair capacity in lung cancer patients. Cancer Res., 56: 4103-4107, 1996.
29. Nakachi, K., Imai, K., Hayashi, S., Watanabe, J., and Kawajiri, K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res., 51: 5177-5180, 1991.
30. Vineis, P., Bartsch, H., Caporaso, N., Harrington, A. M., Kadlubar, F. F., Landi, M. T., Malaveille, C., Shields, G. P., Skipper, P., Talaska, G., and Tannebaum, R. S. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature (Lond.), 369: 154-156, 1996.
31. 32P postlabeling analysis of aromatic DNA adducts in human oral mucosal cells. Carcinogenesis (Lond.), 7: 1115-1120, 1986.
32. 32P-adduct assay. Carcinogenesis (Lond.), 9: 2309-2313, 1988.
33. 32P postlabeling analysis of DNA from exfoliated oral mucosa cells as a means of monitoring exposure of the oral cavity to genotoxic agent. Carcinogenesis (Lond.), 10: 1429-1434, 1989.
34. 32P postlabeling. Cancer Res., 53: 1522-1528, 1993.
35. Romano, G., Mancini, R., Fedele, P., Curigliano, G., Flamini, G., Giovagnoli, R. M., Malara, N., Boninsegna, A., Vecchione, A., Santella, R. M., and Cittadini, A. Immunohistochemical analysis of 4-aminobiphenyl-DNA adducts in oral mucosal cells of smokers and non smokers. Anticancer Res., 17: 2827-2830, 1997.
36. Hsu, T. M., Zhang, Y. J., and Santella, R. M. Immunoperoxidase quantitation of 4-ABP and PAH-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers. Cancer Epidemiol. Biomark., 6: 193-199, 1997.
37. Alexandrov, K., Rojas, M., Kadlubar, F., Lang, N. P., and Bartsch H. Evidence of anti-benzo[a]pyrene diol epoxide-DNA adduct formation in human colon mucosa. Carcinogenesis (Lond.), 17: 2081-2083, 1996.
38. Ryberg, D., Hewer, A., Phillips, D. H., and Haugen, A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res., 54: 5801-5803, 1994.
39. Kure, E. H., Ryberg, D., Hewer, A., Phillips, D. H., Bacra, R., and Haugen, A. p53 mutation in lung tumours: relationship to gender and lung DNA adduct levels. Carcinogenesis (Lond.), 17: 2201-2205, 1996.